Atlas Trials

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Clinical trial NCT06892548 · RECRUITING

Trial details

NCT number
NCT06892548
Sponsor
BioNTech SE
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Lung Cancer
Start date
2025-05-02
Primary completion
2028-09-01
Enrollment
594

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.